260 filings
8-K
BLUE
Bluebird bio Inc
16 Apr 24
Other Events
4:07pm
8-K
BLUE
Bluebird bio Inc
26 Mar 24
Results of Operations and Financial Condition
7:03am
8-K
BLUE
Bluebird bio Inc
18 Mar 24
Entry into a Material Definitive Agreement
8:04am
8-K
BLUE
Bluebird bio Inc
8 Jan 24
Anticipate 85 to 105 patient starts (cell collections) across commercial portfolio in 2024 with first patient start for LYFGENIA expected in Q1 2024
8:03am
8-K
BLUE
Bluebird bio Inc
4 Jan 24
Regulation FD Disclosure
8:00am
8-K
35nxqgva6la xz7gckf0
20 Dec 23
Entry into a Material Definitive Agreement
7:42am
8-K
e843 n08ehxrc
18 Dec 23
Entry into a Material Definitive Agreement
4:48pm
8-K
oxqt5zkm5klflpz4z
14 Dec 23
Regulation FD Disclosure
7:30am
8-K
jo9s3co40b 3wo
11 Dec 23
Regulation FD Disclosure
8:06am
8-K
ybh472c1ixmg
7 Nov 23
Results of Operations and Financial Condition
7:01am
8-K
5g6yja36tzgtv 8dmk4
30 Oct 23
Entry into a Material Definitive Agreement
8:05am
8-K
d3hsu
27 Sep 23
Entry into a Material Definitive Agreement
7:00am
8-K
3zm7thato8902r5 3o4c
8 Aug 23
Entry into a Material Definitive Agreement
9:05am
8-K
g4dhilk6ka07t
8 Aug 23
Regulation FD Disclosure
8:55am
8-K
lj1sned 5s
8 Aug 23
Results of Operations and Financial Condition
7:02am
8-K
xlwcobx u8xh3lxt8ri
12 Jul 23
Regulation FD Disclosure
12:00am
8-K
2pz3w87
20 Jun 23
Amendments to Articles of Incorporation or Bylaws
4:10pm
8-K
nddxbng ens
12 Jun 23
Regulation FD Disclosure
7:28am
8-K
b8v1y4
9 May 23
Results of Operations and Financial Condition
7:03am
8-K
gvi7myi 55k
29 Mar 23
Results of Operations and Financial Condition
7:02am